Association of TPMT (rs1800460) Gene Polymorphism with Childhood Acute Lymphoblastic Leukemia in a Population from Guilan, Iran

Association of TPMT (rs1800460) Gene Polymorphism with Childhood Acute Lymphoblastic Leukemia in a Population from Guilan, Iran

Acute lymphoblastic leukemia (ALL) is a malignant transformation and proliferation of lymphoid progenitor cells in bone marrow and blood, which is mainly found in children. Thiopurine methyltransferase (TPMT) is a thiopurine drug metabolizer enzyme that is prescribed for the treatment of ALL. Severa...

Full description

Bibliographic Details
Main Authors:	Mohammad Hedayati, Hamidreza Vaziri, Bahram Darbandi, Adel Baghersalimi, Mohammadmahdi Jafarzadeh, Ali Salehzadeh
Format:	Article
Language:	English
Published:	University of Mazandaran 2020-09-01
Series:	Journal of Genetic Resources
Subjects:	acute lymphoblastic leukemia childhood blood cancer pmt polymorphism thiopurine methyltransferase
Online Access:	http://sc.journals.umz.ac.ir/article_2789_8dcb6cf9adb5f67063ab194b857b9992.pdf

Similar Items

Detection of Thiopurine S-Methyltransferase (TPMT) Polymorphisms TPMT*3A, TPMT*3B and TPMT*3C in Children with Acute Lymphoblastic Leukemia
by: Nawar S. Mohammed, et al.
Published: (2018-12-01)

TPMT Genetic Variability and Its Association with Hematotoxicity in Indonesian Children with Acute Lymphoblastic Leukemia in Maintenance Therapy
by: Rosdiana DS, et al.
Published: (2021-02-01)

Importance of genotyping of Thiopurine S-methyltransferase in children with acute lymphoblastic leukaemia during maintenance therapy
by: Dokmanović Lidija, et al.
Published: (2008-01-01)

Common Polymorphism’s Analysis of Thiopurine S-Methyltransferase (TPMT) in Iranian Population
by: Mehdi Azad, et al.
Published: (2009-01-01)

Health Technology Assessment of Thiopurine Methyltransferase Testing for Guiding 6-Mercaptopurine Doses in Pediatric Patients with Acute Lymphoblastic Leukemia
by: Donnan, Jennifer
Published: (2009)

Health Technology Assessment of Thiopurine Methyltransferase Testing for Guiding 6-Mercaptopurine Doses in Pediatric Patients with Acute Lymphoblastic Leukemia
by: Donnan, Jennifer
Published: (2009)

EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
by: Kjeld Schmiegelow
Published: (2011-05-01)

EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
by: Kjeld Schmiegelow
Published: (2011-01-01)

In vitro studies of Thiopurine S-Methyltransferase: Ligand binding interactions and development of a new enzymatic activity assay for TPMTwt, TPMT*6 and TPMT*8
by: Hemmingsson, Lovisa, et al.
Published: (2015)

A drug‐repositioning screen for primary pancreatic ductal adenocarcinoma cells identifies 6‐thioguanine as an effective therapeutic agent for TPMT‐low cancer cells
by: Inki Kim, et al.
Published: (2018-09-01)

Establishment of human lymphoma cell lines with different thiopurine S-methyltransferase (TPMT) activities and differential proteome analysis after thiopurine exposure.
by: Misdaq, Misbah
Published: (2013)

Optimisation de la réponse aux thiopurines par la pharmacogénétique : approches in vitro et cliniques
by: Chouchana, Laurent
Published: (2014)

Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population
by: Hamza Ben Zeglam, et al.
Published: (2015-03-01)

Unravelling the Sequential Interplay of Mutational Mechanisms during Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
by: Željko Antić, et al.
Published: (2021-02-01)

The role of polymorphisms of thiopurine methyltransferase in therapy with Azathioprine: preliminary study
by: Francesca Mortillaro, et al.
Published: (2018-11-01)

Ancestry and TPMT-VNTR Polymorphism: Relationship with Hematological Toxicity in Uruguayan Patients with Acute Lymphoblastic Leukemia
by: Gabriela Burgueño-Rodríguez, et al.
Published: (2020-11-01)

Genotypic and phenotypic analysis of the thiopurine S-methyltransferase (TPMT) gene with clinical correlation
by: Cheung, Siu-ping, et al.
Published: (2014)

Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0–45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol
by: Als-Nielsen, B., et al.
Published: (2022)

ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia
by: Borhan Moradveisi, et al.
Published: (2019-08-01)

6-MP based maintenance therapy of childhood ALL in Slovenia: a retrospective study from 1970 to 2004
by: Nataša Karas Kuželički, et al.
Published: (2015-04-01)

Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
by: Hong Zhou, et al.
Published: (2018-05-01)

Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response
by: Abaji R, et al.
Published: (2017-05-01)

Correlation of thiopurine methyltransferase and inosine triphosphate pyrophosphatase polymorphisms and adverse effects induced by azathioprine treatment in Taiwanese dermatology patients
by: Ting-Shun Wang, et al.
Published: (2014-03-01)

<i>TPMT*3C</i> as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia
by: Thawinee Jantararoungtong, et al.
Published: (2021-08-01)

Association between the <i>TPMT*3C</i> (rs1142345) Polymorphism and the Risk of Death in the Treatment of Acute Lymphoblastic Leukemia in Children from the Brazilian Amazon Region
by: Darlen Cardoso de Carvalho, et al.
Published: (2020-09-01)

An Epidemiological Study of Thiopurinemethyltransferase Variants in a Croatian Inflammatory Bowel Disease Patient Cohort
by: Vladimir Borzan, et al.
Published: (2016-01-01)

Effects of TPMT, NUDT15, and ITPA Genetic Variants on 6-Mercaptopurine Toxicity for Pediatric Patients With Acute Lymphoblastic Leukemia in Yunnan of China
by: Xiaoyan Mao, et al.
Published: (2021-10-01)

Biophysical characterization of the *5 protein variant of human thiopurine methyltransferase by NMR spectroscopy
by: Gustafsson, Robert
Published: (2012)

Variants in TPMT, ITPA, ABCC4 and ABCB1 genes as predictors of 6-mercaptopurine induced toxicity in children with acute lymphoblastic leukemia
by: Milošević Goran, et al.
Published: (2018-01-01)

Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia
by: Zou Limin, et al.
Published: (2012-07-01)

STAGE-DEPENDENT IMMUNOPATHOGENETIC FEATURES OF ACUTE NONLYMPHOBLASTIC AND ACUTE LYMPHOBLASTIC LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Acute Lymphoblastic Leukemia and Seizures
by: J Gordon Millichap
Published: (1995-08-01)

Patterns of DNMT1 Promoter Methylation in Patients with Acute Lymphoblastic Leukemia
by: Tirdad Rahmani, et al.
Published: (2016-12-01)

FEATURES OF IMMUNE CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Acute lymphoblastic leukemia in a child presenting primarily with priapism
by: Garima Gupta, et al.
Published: (2020-01-01)

Pancytopenia - (?) An obstacle in the diagnosis and outcome of pediatric acute lymphoblastic leukemia
by: Shruti Raja, et al.
Published: (2015-01-01)

Inactivation of the p15 gene in children with acute lymphoblastic leukemia
by: Rosana Cipolotti, et al.

Risk Factors andthe Most Common Initial Symptoms of Acute Lymphoblastic Leukemia in Children
by: Hashemizadeh H, et al.
Published: (2011-10-01)

Early diagnosis of childhood Acute lymphoblastic leukemia
by: Vanitha Pandey1, Mahesh Kumar K2,Indira3
Published: (2017-04-01)

Novel Tetra-Primer ARMS-PCR Assays for Thiopurine Intolerance Susceptibility Mutations NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C) in East Asians
by: Chi-Chun Ho, et al.
Published: (2017-10-01)